SPEAK OUT!® & LOUD Crowd® Treatment Psychosocial Effects on Parkinson’s Disease
Presenter Type
UNO Graduate Student (Masters)
Major/Field of Study
Special Education and Communication Disorders
Other
Speech Language Pathology
Advisor Information
Dr. Lucia Scheffel
Location
MBSC Ballroom Poster # 901 - G (Masters)
Presentation Type
Poster
Start Date
24-3-2023 9:00 AM
End Date
24-3-2023 10:15 AM
Abstract
Individuals with Parkinson’s Disease (PD) are highly likely to experience challenges associated with speech, language, and communication related to hypokinetic dysarthria. Research suggests individuals with PD benefit clinically from voice therapy while current treatment options are limited. For several years there has been one staple evidence-based voice therapy program for these individuals. As research continues to increase options for this population new treatment programs arise that would benefit from evidence of clinical and functional benefits.
The current study used quality-of-life surveys to attempt to build upon the growing evidence base supporting SPEAK OUT! & LOUD Crowd as a treatment for individuals with PD. Outcomes of this research will be used to support functional benefits of improvements in quality-of-life as well as communicatory participation. Participants in SPEAK OUT! & LOUD Crowd at the UNO Speech and Language Clinic were given pre-and-posttest quality of life surveys and information regarding clinical outcomes was used to compare functional and clinical benefits of this innovative therapy program.
All four participants saw improvements in clinical data for loudness in conversation and sustained /a/. Two of the four participants saw significant improvements in self perceived quality of life based on improvements in their overall speech production and psychosocial effects of speech. One participant had significant improvements to self-perceived quality of life based exclusively on speech scores. Three of four participants had significantly increased communication participation based on self-report.
These results support expected clinical outcomes from using SPEAK OUT! and LOUD Crowd with individuals with PD, as well as increased communication participation for individuals with moderate-marked disease presentation. Additional research is necessary to determine quality of life impacts and their connection to phenotypic differences in PD presentation.
Scheduling
9:15-10:30 a.m., 10:45 a.m.-Noon
SPEAK OUT!® & LOUD Crowd® Treatment Psychosocial Effects on Parkinson’s Disease
MBSC Ballroom Poster # 901 - G (Masters)
Individuals with Parkinson’s Disease (PD) are highly likely to experience challenges associated with speech, language, and communication related to hypokinetic dysarthria. Research suggests individuals with PD benefit clinically from voice therapy while current treatment options are limited. For several years there has been one staple evidence-based voice therapy program for these individuals. As research continues to increase options for this population new treatment programs arise that would benefit from evidence of clinical and functional benefits.
The current study used quality-of-life surveys to attempt to build upon the growing evidence base supporting SPEAK OUT! & LOUD Crowd as a treatment for individuals with PD. Outcomes of this research will be used to support functional benefits of improvements in quality-of-life as well as communicatory participation. Participants in SPEAK OUT! & LOUD Crowd at the UNO Speech and Language Clinic were given pre-and-posttest quality of life surveys and information regarding clinical outcomes was used to compare functional and clinical benefits of this innovative therapy program.
All four participants saw improvements in clinical data for loudness in conversation and sustained /a/. Two of the four participants saw significant improvements in self perceived quality of life based on improvements in their overall speech production and psychosocial effects of speech. One participant had significant improvements to self-perceived quality of life based exclusively on speech scores. Three of four participants had significantly increased communication participation based on self-report.
These results support expected clinical outcomes from using SPEAK OUT! and LOUD Crowd with individuals with PD, as well as increased communication participation for individuals with moderate-marked disease presentation. Additional research is necessary to determine quality of life impacts and their connection to phenotypic differences in PD presentation.